Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Fed & Macro

Federal Funds Rate

The Fed's benchmark overnight interest rate that anchors borrowing costs across the entire economy.

Also known as: Fed Funds Rate, Policy Rate

What it is
The federal funds rate is the target interest rate the FOMC sets for overnight lending between banks. It is the base rate that ripples into loans, mortgages, and yields economy-wide. The Fed steers it via open-market operations and administered rates.
What it does
Changes in the funds rate reprice discount rates, hitting long-duration growth stocks hardest and reshaping bank margins. Rate cuts generally favor rate-sensitive and cyclical assets; hikes pressure them. Investors position sectors around the rate path.
The evidence
Rate-hike cycles have compressed valuations on long-duration tech while aiding net-interest margins at banks.
Best for
Banks (XLF), rate-sensitive tech (XLK), real estate (XLRE), bonds (TLT).
Pairs well with
fomc, yield-curve, quantitative-tightening
Use cautiously with
The market trades the expected path, not the current level; a hike can rally stocks if it is dovish versus expectations.
Cautions
Second-order effects and forward guidance often matter more than the single move.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More fed & macro

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →